EPA

Epa is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19347 references associated with EPA in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for EPA

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with EPA

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Sarcoma, Experimental D012513 13 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Hyperglycemia D006943 21 associated lipids
Per page 10 20 50 100 | Total 140

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with EPA

Download all related citations
Per page 10 20 50 100 | Total 4880
Authors Title Published Journal PubMed Link
McDaniel JC et al. Omega-3 fatty acids effect on wound healing. 2008 May-Jun Wound Repair Regen pmid:18471252
McDaniel JC et al. Fish oil supplementation alters levels of lipid mediators of inflammation in microenvironment of acute human wounds. 2011 Mar-Apr Wound Repair Regen pmid:21362086
Okuyama H [Need to change the direction of cholesterol-related medication--a problem of great urgency]. 2005 Yakugaku Zasshi pmid:16272805
Yano T et al. [Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on low density lipoprotein in rabbits]. 1995 Yakugaku Zasshi pmid:8531063
Shin MJ et al. Increased inflammation, reduced plasma phospholipid eicosapentaenoic acid and reduced antioxidant potential of treated hypertensive patients with metabolic syndrome. 2009 Yonsei Med. J. pmid:20046414
Reuter W and Zander B [Effect of propranolol treatment on blood omega-3-fatty acids in hypertension in middle age]. 1988 Mar-Apr Z Alternsforsch pmid:2837007
Singer P et al. [Changes in blood pressure and serum lipids with fish diets in patients with mild essential hypertension]. 1986 Z Gesamte Inn Med pmid:3006368
Herrmann W and Beitz J [Decreasing atherogenic risks by an eicosapentaenoic acid-rich diet]. 1987 Z Gesamte Inn Med pmid:3035811
Herrmann W et al. [An eicosapentaenoic acid-rich diet in relation to a reducing diet and physical training]. 1987 Z Gesamte Inn Med pmid:2820157
Reuter W et al. [Modification of vasoprotective omega-3-fatty acids--a previously unknown side effect of propranolol therapy?]. 1988 Z Gesamte Inn Med pmid:2838979